Japan’s Eisai aims to silence critics over breakthrough Alzheimer’s drug

Shares fall 11% following two patient deaths in trials of lecanemab
Source: FT.com - Drugs and Healthcare - Category: Pharmaceuticals Source Type: news
More News: Pharmaceuticals